ZHBIO(SZ:300653) Zheng Quan Ri Bao Wang·2025-09-17 09:45Core Viewpoint - Zhenghai Biological (300653) has reported that it is actively participating in volume-based procurement for its meninges products across multiple provinces, indicating a strategic response to market changes and regulatory developments [1] Group 1: Company Developments - As of now, six provincial and two inter-provincial alliances have initiated volume-based procurement for meninges products, covering a total of 24 provinces (autonomous regions and corps) [1] - The company has successfully won bids for its meninges series in all provinces where centralized procurement has been implemented, leading to a stable market share despite price reductions [1] Group 2: Market Impact - The centralized procurement has resulted in a decrease in the selling price of the company's meninges products, which has correspondingly increased sales volume [1] - The company is preparing for upcoming volume-based procurement projects, particularly in response to a notification from Tianjin regarding the maintenance of medical consumables information for hard brain (spinal) membrane patches [1]